Researchers identify 166 human pluripotent stem cell lines available for use in clinical applications

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have entered early developmental pipelines. For…

Continue Reading

News Source: medicalxpress.com